Provider profile
3PBIOVIAN.
Biologics CDMOs
3PBIOVIAN, formed from 3P Biopharmaceuticals and Biovian, describes process, cell line and analytical development and GMP manufacturing of microbial and mammalian proteins, including monoclonal antibodies, plus AAV and adenovirus vectors and plasmid DNA, for drug substance and in-house fill and finish, from preclinical to commercial supply. It lists manufacturing sites in Noáin (Pamplona), Spain and Turku, Finland.
- Website
- 3pbiovian.com (opens in a new tab)
- Sources reviewed
- November 4, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
- Analytical development and QC testing1,3
- Cell line development3,4
- Clinical packaging and labeling3,6Stated for AAV and adenovirus vector products
- Formulation development4Listed within mammalian protein manufacturing services
- GMP drug product manufacturing3,5Stated for AAV viral vectors (QP-approved release of labeled drug product)
- GMP drug substance manufacturing5
- Process development1,2
- Stability studies1Listed under quality control for the AAVion AAV platform
- Technology transfer2
Platforms and methods
Development experience
Development experience
Modality
- Cell therapies5Listed as a service offering; no cell therapy service page was reviewed
- Gene therapies9,10,11
- Monoclonal antibodies4
- mRNA and nucleic acids3Plasmid DNA manufacturing only; mRNA not established
- Recombinant proteins2,4
- Vaccines6Stated as adenovirus vector manufacturing for vaccine applications
Locations
Locations
- Turku, Finland · Manufacturing site12Manufacturing site (Biocity, Turku); reviewed pages do not state which products each site makes
- Noáin, Spain · Manufacturing site5Listed by the company as its Pamplona (Pamplona-Noáin) manufacturing site; reviewed pages do not state which products each site makes
- Boston, United States · Office5Office address listed under company locations
Quality and regulatory
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Available capacity, slot timing and scale for your next campaign
- Recent experience with your specific modality and expression system or chemistry
- Regulatory inspection history of the specific site that would manufacture your product
- Technology-transfer approach, timeline and who owns the resulting process knowledge
- Analytical and QC release testing done in-house versus subcontracted
- Quality agreement terms, batch-failure responsibility and change-order mechanics
Evidence and sources
Evidence and sources
- 1AAV CDMO : Expert Viral Vector Manufacturing Services | 3PBIOVIAN (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2Microbial Manufacturing Services | 3PBIOVIAN (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3AAV Production Service | 3PBIOVIAN (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4Mammalian Manufacturing Services | 3PBIOVIAN (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5Global CDMO // 3PBIOVIAN / Affinity in the making. (opens in a new tab)3PBIOVIAN · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 6Adenovirus Manufacturing | 3PBIOVIAN (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 7AAV Plasmid Production // 3PBIOVIAN / Affinity in the making (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 8Adenovirus Upstream Processes // 3PBIOVIAN / Affinity in the making (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 9Cell Banking & Virus Seed Stock Manufacturing // 3PBIOVIAN (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 10AAV Cell Banking // 3PBIOVIAN / Affinity in the making (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 11Adenovirus Downstream Processes // 3PBIOVIAN / Affinity in the making (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 12Biologics CDMO & Biopharmaceutical Manufacturing Services | 3PBIOVIAN (opens in a new tab)Biovian · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its website (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.